Epidemiology and Ecology of Leishmaniasis
Author:
Open Access
- 4 December 2019
- book chapter
- Published by IntechOpen
Abstract
Leishmaniasis is the third most important vector-borne disease after malaria and lymphatic filariasis. It is common disease in all over the world. The vector for leishmaniasis is Phlebotomus and there have found around 20 different types of this vector. There are different clinical forms under the name of leishmaniasis such as kala-azar, dum-dum fever, white leprosy, espundia, pian bois, chiclero’s ulcer, uta. Environmental factors leading to climate changes and global warming are major risk factors for the spreading of the disease. Leishmania spp. to prevent the spread of the definitive host and intermediate hosts is difficult compared to Plasmodium spp. Therefore; leishmaniasis disease will retain its importance for many years.Keywords
This publication has 51 references indexed in Scilit:
- Moroccan Leishmania infantum: Genetic Diversity and Population Structure as Revealed by Multi-Locus Microsatellite TypingPLOS ONE, 2013
- Cutaneous Leishmaniasis “Chiclero's Ulcer” in Subtropical EcuadorThe American Journal of Tropical Medicine and Hygiene, 2013
- LeishmaniaResistance to Miltefosine Associated with Genetic MarkerEmerging Infectious Diseases, 2012
- Molecular Detection of Leishmania infantum in Wild Rodents (Rattus norvegicus) in GreeceZoonoses and Public Health, 2010
- Activity Patterns of Sand Fly (Diptera: Psychodidae) Species and Comparative Performance of Different Traps in an Endemic Cutaneous Leishmaniasis Focus in Cukurova Plain, Southern Anatolia, TurkeyActa Veterinaria Brno, 2009
- Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part oneTrends in Parasitology, 2008
- The Relationship between Leishmaniasis and AIDS: the Second 10 YearsClinical Microbiology Reviews, 2008
- Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomyProceedings of the National Academy of Sciences, 2007
- A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S o Gon alo do Amaranto, RN)Vaccine, 2000
- Phase I and II open clinical trials of a vaccine against Leishmania chagasi Infections in dogsMemórias do Instituto Oswaldo Cruz, 1996